Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19(+)B-cell repopulation

por Sahi, Nitin Kumar, Abidi, Syed Muhammad Ali, Salim, Omar, Abraham, Roby, Kalra, Seema, Al-Araji, Adnan
Publicado 2021

Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations

por Kalra, Seema, Silman, Alan, Akman-Demir, Gulsen, Bohlega, Saeed, Borhani-Haghighi, Afshin, Constantinescu, Cris S., Houman, Habib, Mahr, Alfred, Salvarani, Carlos, Sfikakis, Petros P., Siva, Aksel, Al-Araji, Adnan
Publicado 2013